| Walmart Pharmacy 10-4683 | |
| 10550 Burbank Dr, Baton Rouge, Louisiana 70810 | |
| (225) 412-5498 |
| Name | Walmart Pharmacy 10-4683 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 10550 Burbank Dr, Baton Rouge, Louisiana 70810 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (225) 412-5498 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In collaboration with colleagues from across Europe, researchers from the University of Copenhagen and the Mental Health Services in the Capital Region of Denmark have found mutations in the human genome that lead to an increased risk of developing schizophrenia.
Imagine you cannot move your eyes up, and you cannot lift your upper eyelid. You walk through life with your head tilted upward so that your eyes look straight when they are rolled down in the eye socket.
Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.
Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced the presentation of Phase 2 data from two of the Company's ongoing clinical trials (SB-728-1101 Cohort 3* and SB-728-mR-1401) of SB-728-T, which is being developed for the functional control of HIV/AIDS.
› Verified 5 days ago
| NPI Number | 1346667821 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WALMART PHARMACY 10-4683 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 10550 Burbank Dr, Baton Rouge, LA 70810 |
| Phone Number | 225-412-5498 |
News Archive
In collaboration with colleagues from across Europe, researchers from the University of Copenhagen and the Mental Health Services in the Capital Region of Denmark have found mutations in the human genome that lead to an increased risk of developing schizophrenia.
Imagine you cannot move your eyes up, and you cannot lift your upper eyelid. You walk through life with your head tilted upward so that your eyes look straight when they are rolled down in the eye socket.
Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.
Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced the presentation of Phase 2 data from two of the Company's ongoing clinical trials (SB-728-1101 Cohort 3* and SB-728-mR-1401) of SB-728-T, which is being developed for the functional control of HIV/AIDS.
› Verified 5 days ago
News Archive
In collaboration with colleagues from across Europe, researchers from the University of Copenhagen and the Mental Health Services in the Capital Region of Denmark have found mutations in the human genome that lead to an increased risk of developing schizophrenia.
Imagine you cannot move your eyes up, and you cannot lift your upper eyelid. You walk through life with your head tilted upward so that your eyes look straight when they are rolled down in the eye socket.
Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.
Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced the presentation of Phase 2 data from two of the Company's ongoing clinical trials (SB-728-1101 Cohort 3* and SB-728-mR-1401) of SB-728-T, which is being developed for the functional control of HIV/AIDS.
› Verified 5 days ago
Action Rehab And Supply Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1443 Delplaza Dr, Baton Rouge, Louisiana 70815 Phone: (225) 214-1260 | |
Aids Healthcare Foundation Type: Community/Retail Pharmacy Location: 4890 Bluebonnet Blvd, Baton Rouge, Louisiana 70809 Phone: (225) 297-4430 | |
Sav On Pharmacy #3792 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9960 Bluebonnet Blvd, Baton Rouge, Louisiana 70810 Phone: (225) 768-7950 | |
Sav-on Pharmacy #0709 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2950 College Dr, Baton Rouge, Louisiana 70808 Phone: (225) 924-6094 | |
Sav-on Pharmacy #0712 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9650 Airline Hwy, Baton Rouge, Louisiana 70815 Phone: (225) 926-9604 |